Light Rain 64°
Lifestyle
COVID-19: Vaccinated Americans Get Green Light To Travel, Should Take These Measures, CDC Says COVID-19: Vaccinated Americans Get Green Light To Travel, Should Take These Measures, CDC Says
Covid-19: Vaccinated Americans Get Green Light To Travel, Should Take These Measures, CDC Says Fully vaccinated Americans can resume domestic and overseas travel as long as they wear masks in public, and follow two other measures, according to brand-new guidance from the Centers for Disease Control & Prevention (CDC). They also don't need to be tested for COVID-19 before or after domestic travel and don't have to self-quarantine on return, provided they follow public health measures. The CDC released the guidance on Friday, April 2.  In addition to wearing a mask, fully vaccinated travelers should also: Stay 6 feet from others and avoid crowds Wash your hands often or use…

SHARE

by Joe Lombardi
Lifestyle
COVID-19: Got Your Vaccine? Here's What This Popular Food Chain Will Give You For Free COVID-19: Got Your Vaccine? Here's What This Popular Food Chain Will Give You For Free
Covid-19: Got Your Vaccine? Here's What This Popular Food Chain Will Give You For Free One of the country’s most popular food chains is offering a sweet incentive to encourage Americans to go out and get their COVID-19 vaccination. Krispy Kreme is sweetening the deal for anyone on the fence about getting the vaccine by offering a free daily doughnut at each of their U.S. locations through the end of 2021. No purchase is required to pick up the free treat, one just has to provide proof that they’ve been vaccinated. According to Krispy Kreme, those qualified for the free doughnut include anyone who has received one of the two shots of the Moderna or Pfizer COVID-19 vaccine, o…

SHARE

by Zak Failla
News
COVID-19: Moderna Begins Vaccine Trials For Children, Babies COVID-19: Moderna Begins Vaccine Trials For Children, Babies
Covid-19: Moderna Begins Vaccine Trials For Children, Babies Moderna is moving forward with its latest COVID-19 vaccine trial, testing it in children six months to less than 12 years old as the company reviews the effectiveness and safety of the shot in younger Americans. As part of the study, researchers will be giving two injections 28 days apart of either the Moderna vaccine or a placebo, to the children being tested. The current Moderna vaccine has only been authorized for use in those 18 and older. Kids who get the vaccine will receive one of three possible doses, from 25 micrograms up to 100 micrograms – the same dose that received an emergen…

SHARE

by Zak Failla
News
COVID-19: CDC Unveils Highly-Anticipated Guidelines For Those Who Are Fully Vaccinated COVID-19: CDC Unveils Highly-Anticipated Guidelines For Those Who Are Fully Vaccinated
Covid-19: CDC Unveils Highly-Anticipated Guidelines For Those Who Are Fully Vaccinated The Centers for Disease Control & Prevention (CDC) has just issued its first guidance for fully vaccinated people during the COVID-19 pandemic. Those who currently count as fully vaccinated are those who have gotten two separate shots of the Pfizer and Moderna vaccines with the second shot coming at least two weeks ago. The rollout for the single-dose Johnson & Johnson vaccine started last week. According to the CDC guidance released late Monday morning, March 8, fully vaccinated people should still: Maintain physical distance in public and wear a well-fitted mask Avoid large- and…

SHARE

by Joe Lombardi
News
COVID-19: Massachusetts Among Top 10 Hotspots For Virus Variants COVID-19: Massachusetts Among Top 10 Hotspots For Virus Variants
Covid-19: Massachusetts Among Top 10 Hotspots For Virus Variants Massachusetts has become a hotspot for a new virus variant of COVID-19. SARS-CoV-2 has one or more mutations that differentiate it from the predominant coronavirus already circulating, the U.S. Centers for Disease Control and Prevention said. The CDC has been tracking these mutated COVID-19 viruses around the country. On Friday, March 5, Massachusetts was the state with the 10th most incidents of COVID-19 variants reported. There have been 3,390 instances of SARS CoV-2 in Massachusetts since January 2020, the CDC said. The states that have endured the most COVID-19 virus variants are Calif…

SHARE

by Kristin Palpini
News
COVID-19: One-Dose, Easy-To-Store New Vaccine Gets FDA Approval, Nears OK For Emergency Use COVID-19: One-Dose, Easy-To-Store New Vaccine Gets FDA Approval, Nears OK For Emergency Use
Covid-19: One-Dose, Easy-To-Store New Vaccine Gets FDA Approval, Nears OK For Emergency Use The Food and Drug Administration's staff has endorsed Johnson & Johnson’s COVID-19 vaccine for emergency use, paving the way for the one-dose shot to receive its final approval for emergency use in America by a final committee. This week, the FDA announced it supported the approval of the vaccine, which is easier to store and would represent a third vaccination option for those looking to get inoculated as the country combats the virus. The FDA’s Vaccines and Related Biological Products Advisory Committee is expected to meet on Friday, Feb. 26 to determine whether the new vaccine is via…

SHARE

by Zak Failla
News
COVID-19: Delaying Second Vaccine Could Create 'Fast-Spreading' Virus Variants, Fauci Says COVID-19: Delaying Second Vaccine Could Create 'Fast-Spreading' Virus Variants, Fauci Says
Covid-19: Delaying Second Vaccine Could Create 'Fast-Spreading' Virus Variants, Fauci Says Skipping or delaying taking a recommended second dose of the COVID-19 vaccine could be riskier than previously thought. On Monday, Feb. 8, Dr. Anthony Fauci said that if the U.S. does not adhere to the established vaccination schedule of two doses administered weeks apart, the situation could give rise to new, fast-spreading COVID-19 virus variants. The most common COVID-19 vaccines in the U.S. are mRNA-type vaccines produced by Pfizer or Moderna. While the first dose of an mRNA vaccine provides some protection, the second dose is needed to boost immunity to its most effective level. Dosa…

SHARE

by Kristin Palpini
News
COVID-19: Johnson & Johnson Releases Trial Results For One-Dose Vaccine COVID-19: Johnson & Johnson Releases Trial Results For One-Dose Vaccine
Covid-19: Johnson & Johnson Releases Trial Results For One-Dose Vaccine Some relief may be on the way for the millions of people awaiting their turn to receive the COVID-19 vaccine. Johnson & Johnson has been developing a single-dose vaccine for COVID-19, which has an efficacy rate of approximately 72 percent, potentially bringing another provider into the mix as vaccines for the virus have become a valuable and scarce commodity. If it is ultimately approved by federal health officials, the Johnson & Johnson vaccine would join Pfizer and Moderna on the market, both of which require two doses administered approximately three weeks apart. However, the ef…

SHARE

by Zak Failla
News
COVID-19: Third Vaccine Approved For Use COVID-19: Third Vaccine Approved For Use
Covid-19: Third Vaccine Approved For Use A new COVID-19 vaccine that has proven effective in recent testing has been the third vaccine to gain approval. Developed by Oxford University in the United Kingdom by AstraZeneca and dubbed the “vaccine for the world,” the vaccine is nearly ready to begin distribution. Pfizer distributed the first COVID-19 vaccine, followed by Moderna's vaccine. Both are now been administered in the United States. Approximately 530,000 doses of the new vaccine are expected to be ready as soon as early next week, while the UK has reportedly ordered 100 million doses of the vaccine, which will allow them to…

SHARE

by Zak Failla
News
COVID-19: Distribution At Nursing Homes First Step To Getting Vaccines To Pharmacies, CVS Says COVID-19: Distribution At Nursing Homes First Step To Getting Vaccines To Pharmacies, CVS Says
Covid-19: Distribution At Nursing Homes First Step To Getting Vaccines To Pharmacies, CVS Says CVS and other major pharmacies have launched the company’s COVID-19 vaccination program, which will begin at long-term health care facilities where the population is at the highest risk to contract the virus and potentially die. The company announced that its teams will begin administering the first dose of COVID-19 vaccines produced by Pfizer across 40,000 facilities in 12 states as soon as this week. Walgreens and other pharmacies are also involved in the federal nursing home vaccination program. Related story - COVID-19: Cuomo Calls On Airlines To Do Pre-Flight Testing From UK Due…

SHARE

by Zak Failla
News
COVID-19: FDA Approves Home Test, Calls Moderna Vaccine 'Highly Effective' COVID-19: FDA Approves Home Test, Calls Moderna Vaccine 'Highly Effective'
Covid-19: FDA Approves Home Test, Calls Moderna Vaccine 'Highly Effective' The Food and Drug Administration approved the first over-the-counter COVID-19 test involving a nasal swab that provides results in under a half-hour and is now likely to give an OK to Moderna’s COVID-19 vaccine, which it dubbed “highly effective." The new home test for COVID marks the first that doesn’t have to be sent to a lab to receive the results. Health officials with the FDA have authorized more than 225 diagnostic tests for COVID-19 since the start of the pandemic, including more than 25 tests that allow for home collection of samples, which are then sent to a lab for testing. “By …

SHARE

by Zak Failla
News
COVID-19: Massachusetts' Supply Of Vaccines Slashed By 20 Percent COVID-19: Massachusetts' Supply Of Vaccines Slashed By 20 Percent
Covid-19: Massachusetts' Supply Of Vaccines Slashed By 20 Percent Massachusetts’ share of Pfizer vaccine doses just got cut by 20 percent. On Friday, Dec. 18, Gov. Charlie Baker said that the state is expecting to receive 145,000 doses of the vaccine this month, according to the Boston Business Journal. But it was initially supposed to be 180,000 doses. Massachusetts isn’t alone in thinking it was going to get more vaccines than it is. California, Washington, Illinois, Georgia, Hawaii, and Nevada say the number of doses they were to receive was cut in half, according to reporting by the Associated Press. During his daily press conference, Baker said he…

SHARE

by Kristin Palpini